176 related articles for article (PubMed ID: 23593417)
21. A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment.
Storer TW; Woodhouse LJ; Sattler F; Singh AB; Schroeder ET; Beck K; Padero M; Mac P; Yarasheski KE; Geurts P; Willemsen A; Harms MK; Bhasin S
J Clin Endocrinol Metab; 2005 Aug; 90(8):4474-82. PubMed ID: 15914526
[TBL] [Abstract][Full Text] [Related]
22. Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension.
Falutz J; Potvin D; Mamputu JC; Assaad H; Zoltowska M; Michaud SE; Berger D; Somero M; Moyle G; Brown S; Martorell C; Turner R; Grinspoon S
J Acquir Immune Defic Syndr; 2010 Mar; 53(3):311-22. PubMed ID: 20101189
[TBL] [Abstract][Full Text] [Related]
23. A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with schizophrenia.
Henderson DC; Fan X; Sharma B; Copeland PM; Borba CP; Boxill R; Freudenreich O; Cather C; Eden Evins A; Goff DC
Acta Psychiatr Scand; 2009 Jun; 119(6):457-65. PubMed ID: 19183127
[TBL] [Abstract][Full Text] [Related]
24. [Effect of recombinant human growth hormone on glucose metabolism in children with growth hormone deficiency].
Liang L; Zou CC; Li Y; Wang CL; Jiang YJ; Dong GP; Fu JF; Wang XM
Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):657-61. PubMed ID: 17217656
[TBL] [Abstract][Full Text] [Related]
25. Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition, visceral fat, lipid, glucose and adipokine metabolism.
Samaras K; Wand H; Law M; Emery S; Cooper DA; Carr A
Curr HIV Res; 2009 Jul; 7(4):454-61. PubMed ID: 19601783
[TBL] [Abstract][Full Text] [Related]
26. Effects of recombinant human growth hormone in anorexia nervosa: a randomized, placebo-controlled study.
Fazeli PK; Lawson EA; Prabhakaran R; Miller KK; Donoho DA; Clemmons DR; Herzog DB; Misra M; Klibanski A
J Clin Endocrinol Metab; 2010 Nov; 95(11):4889-97. PubMed ID: 20668047
[TBL] [Abstract][Full Text] [Related]
27. Effect of rosiglitazone and metformin on insulin resistance in patients infected with human immunodeficiency virus receiving highly active antiretroviral therapy containing protease inhibitor: randomized prospective controlled clinical trial.
Silic A; Janez A; Tomazic J; Karner P; Vidmar L; Sharma P; Maticic M
Croat Med J; 2007 Dec; 48(6):791-9. PubMed ID: 18074413
[TBL] [Abstract][Full Text] [Related]
28. Effects of a combination of rhGH and metformin on adiponectin levels in patients with metabolic syndrome.
Herrmann BL; Saller B; Stratmann M; Berg C; Mann K; Janssen OE
Horm Metab Res; 2005 Jan; 37(1):49-52. PubMed ID: 15702440
[TBL] [Abstract][Full Text] [Related]
29. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
[TBL] [Abstract][Full Text] [Related]
30. No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial.
Carr A; Workman C; Carey D; Rogers G; Martin A; Baker D; Wand H; Law M; Samaras K; Emery S; Cooper DA;
Lancet; 2004 Feb; 363(9407):429-38. PubMed ID: 14962523
[TBL] [Abstract][Full Text] [Related]
31. GH treatment reduces trunkal adiposity in HIV-infected patients with lipodystrophy: a randomized placebo-controlled study.
Luzi L; Meneghini E; Oggionni S; Tambussi G; Piceni-Sereni L; Lazzarin A
Eur J Endocrinol; 2005 Dec; 153(6):781-9. PubMed ID: 16322383
[TBL] [Abstract][Full Text] [Related]
32. Effects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trial.
Bredella MA; Lin E; Brick DJ; Gerweck AV; Harrington LM; Torriani M; Thomas BJ; Schoenfeld DA; Breggia A; Rosen CJ; Hemphill LC; Wu Z; Rifai N; Utz AL; Miller KK
Eur J Endocrinol; 2012 Apr; 166(4):601-11. PubMed ID: 22275471
[TBL] [Abstract][Full Text] [Related]
33. A randomized, placebo-controlled trial of rosiglitazone for HIV-related lipoatrophy.
Cavalcanti RB; Raboud J; Shen S; Kain KC; Cheung A; Walmsley S
J Infect Dis; 2007 Jun; 195(12):1754-61. PubMed ID: 17492590
[TBL] [Abstract][Full Text] [Related]
34. Effects of insulin-like growth factor (IGF)-I/IGF-binding protein-3 treatment on glucose metabolism and fat distribution in human immunodeficiency virus-infected patients with abdominal obesity and insulin resistance.
Rao MN; Mulligan K; Tai V; Wen MJ; Dyachenko A; Weinberg M; Li X; Lang T; Grunfeld C; Schwarz JM; Schambelan M
J Clin Endocrinol Metab; 2010 Sep; 95(9):4361-6. PubMed ID: 20610601
[TBL] [Abstract][Full Text] [Related]
35. A placebo-controlled, dose-ranging study of a growth hormone releasing factor in HIV-infected patients with abdominal fat accumulation.
Falutz J; Allas S; Kotler D; Thompson M; Koutkia P; Albu J; Trottier B; Routy JP; Cote P; Abribat T; Grinspoon S
AIDS; 2005 Aug; 19(12):1279-87. PubMed ID: 16052083
[TBL] [Abstract][Full Text] [Related]
36. Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity.
Bhasin S; Parker RA; Sattler F; Haubrich R; Alston B; Umbleja T; Shikuma CM;
J Clin Endocrinol Metab; 2007 Mar; 92(3):1049-57. PubMed ID: 17164307
[TBL] [Abstract][Full Text] [Related]
37. Effects of metformin and rosiglitazone on peripheral insulin resistance and β-cell function in obesity: a double-blind, randomized, controlled study.
Li X; Zhang N; Li Y; Shi Y; Li D; Xie Y; Xie Y; Ming J
J Int Med Res; 2011; 39(2):358-65. PubMed ID: 21672339
[TBL] [Abstract][Full Text] [Related]
38. Two years of replacement therapy in adults with growth hormone deficiency.
Verhelst J; Abs R; Vandeweghe M; Mockel J; Legros JJ; Copinschi G; Mahler C; Velkeniers B; Vanhaelst L; Van Aelst A; De Rijdt D; Stevenaert A; Beckers A
Clin Endocrinol (Oxf); 1997 Oct; 47(4):485-94. PubMed ID: 9404448
[TBL] [Abstract][Full Text] [Related]
39. Randomized controlled trial to determine the efficacy of long-term growth hormone treatment in severely burned children.
Branski LK; Herndon DN; Barrow RE; Kulp GA; Klein GL; Suman OE; Przkora R; Meyer W; Huang T; Lee JO; Chinkes DL; Mlcak RP; Jeschke MG
Ann Surg; 2009 Oct; 250(4):514-23. PubMed ID: 19734776
[TBL] [Abstract][Full Text] [Related]
40. Effects of recombinant growth hormone on visceral fat accumulation: pilot study in human immunodeficiency virus-infected adolescents.
Viganò A; Mora S; Manzoni P; Schneider L; Beretta S; Molinaro M; di Natale B; Brambilla P
J Clin Endocrinol Metab; 2005 Jul; 90(7):4075-80. PubMed ID: 15840750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
